Cargando…
Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors
The development of selective butyrylcholinesterase (BChE) inhibitors may improve the treatment of Alzheimer’s disease by increasing lower synaptic levels of the neurotransmitter acetylcholine, which is hydrolysed by acetylcholinesterase, as well as by overexpressed BChE. An increase in the synaptic...
Autores principales: | Baumann, Krešimir, Kordić, Lorena, Močibob, Marko, Šinko, Goran, Tomić, Srđanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695897/ https://www.ncbi.nlm.nih.gov/pubmed/31382668 http://dx.doi.org/10.3390/molecules24152833 |
Ejemplares similares
-
Preparation of Novel meta- and para-Substituted N-Benzyl Protected Quinuclidine Esters and Their Resolution with Butyrylcholinesterase
por: Primožič, Ines, et al.
Publicado: (2012) -
Evaluation of the Key Structural Features of Various Butyrylcholinesterase Inhibitors Using Simple Molecular Descriptors
por: Miličević, Ante, et al.
Publicado: (2022) -
Assessment of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase
por: Čadež, Tena, et al.
Publicado: (2021) -
β-d-Galactopyranosyl-(1→4)–2-amino-2-deoxy-α-d-glucopyranose hydrochloride monohydrate (lactosamine)
por: Mossine, Valeri V., et al.
Publicado: (2022) -
Synthesis of Highly Oxygenated Bicyclic Carbasugars. Remarkable Difference in the Reactivity of the d-gluco and d-xylo- Derived Trienes
por: Witkowski, Grzegorz, et al.
Publicado: (2020)